OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways
Jing Li(Tufts Medical Center), David Cory Adamson(Mercer University)
Cited by 28
Related Papers
No related papers found
Powered by citation graph analysis